HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation between circulating blood and microenvironment T lymphocytes in diffuse large B-cell lymphomas.

AbstractAIMS:
Diffuse large B-cell lymphoma (DLBCL) is characterised by marked clinical and biological heterogeneity, attributable to the tumour cells and their microenvironment.
METHODS:
In this study, we investigated circulating subsets of blood lymphocytes and monocytes and their relationship with T cells in the tumour microenvironment (TME) in chemoresistant and chemosensitive patients with DLBCL.
RESULTS:
The study showed that (1) absolute lymphocyte count (ALC) and CD3+ and CD4+ cells were reduced in chemoresistant patients compared with chemosensitive patients; (2) lymphocyte:monocyte ratio (LMR) showed a positive correlation with peripheral blood CD3+ and CD4+ cells; (3) ALC, LMR, peripheral blood CD3+ and CD4+ cells showed a positive correlation with T cells in the TME.
CONCLUSIONS:
Overall, these data suggest that DLBCL with high TME T cells display a pre-existing antitumour immune response. In the rituximab-containing regimen, TME T cells are stimulated further to participate in the immune response against lymphoma cells. In contrast, DLBCL lymphomas with low T-cell infiltration reflect the absence of a pre-existing antitumour immunity and have a lower likelihood of obtaining an optimal response to therapy.
AuthorsFilomena Emanuela Laddaga, Giuseppe Ingravallo, Anna Mestice, Roberto Tamma, Tommasina Perrone, Eugenio Maiorano, Domenico Ribatti, Giorgina Specchia, Francesco Gaudio
JournalJournal of clinical pathology (J Clin Pathol) Vol. 75 Issue 7 Pg. 493-497 (Jul 2022) ISSN: 1472-4146 [Electronic] England
PMID34011621 (Publication Type: Journal Article)
Copyright© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Topics
  • Humans
  • Lymphocyte Count
  • Lymphocytes (pathology)
  • Lymphoma, Large B-Cell, Diffuse (pathology)
  • Monocytes (pathology)
  • Prognosis
  • Tumor Microenvironment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: